Full Year 2023 Vimian Group AB Earnings Call Transcript
()-
Good morning and thank you very much for joining us today and welcome to the Vimian Q4 and yearend earnings call. I'm Patrik Eriksson and I joined Vimian as the CEO in January.
With me here today is our CFO, Carl-Johan Zetterberg, who will present the quarterly results and [Julie Sperry] CEO. of Navarra, who will give you an update on our MedTech segment. I've been we've been there now for a few weeks spending most of my time getting to know the business solely visiting our different sites and our customers the veterinary clinics. I've met a committed and highly dedicated team. I think we have a strong product portfolio of well-known brands with attractive exposure to high-growth market niches and strong relationships with veterinary community, including several key opinion leaders.
I've spent the past 20 years of my career leading global MedTech businesses with up to $1.5 billion in revenue for almost a decade. I worked for Danaher, a New York stock listed company, which has very many similarities with Vimian
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |